Warren Foust - May 8, 2023 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
Chief Operating Officer
Signature
/s/ Samuel J. Gesten as attorney-in-fact for Warren Foust
Stock symbol
STAA
Transactions as of
May 8, 2023
Transactions value $
$0
Form type
4
Date filed
5/9/2023, 05:24 PM
Previous filing
Mar 29, 2023
Next filing
Mar 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STAA Common Stock Options Exercise $0 +20.3K $0.00 20.3K May 8, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Common Stock Options Options Exercise $0 +37.6K $0.00 37.6K May 8, 2023 Common Stock 37.6K $67.63 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of 20,331 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the shares (6777) on 5/08/24, 1/3 of the shares (6777) on 5/08/25, and 1/3 of the shares (6777) on 5/08/26.
F2 The options granted become exercisable as follows: 1/3 on 5/08/2024 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 5/08/2026.

Remarks:

This Form 4 reflects the equity grant to Mr. Foust related to his appointment as Chief Operating Officer.